Atara Biotherapeutics, Inc. (NASDAQ:ATRA) has reached the top gainers list today as the stock has jumped 11.50% from the open, touching $41.70 on a recent bid. The year-to-date performance of the stock is 130.39%. The monthly stock performance comes in at 101.45%. For the quarter, shares are performing at 190.59%. Weekly performance analysis shows the equity at 26.17%.Covering Sell-Side analysts have offered recommendations and price target estimates on Atara Biotherapeutics, Inc. (NASDAQ:ATRA). According to First Call, the current consensus target price on shares is sitting at $34.20. Analysts have also given a consensus recommendation on the stock of 1.90. This number lands on a scale from 1 to 5. A rating of 4 or 5 would indicate a Sell. A rating of 1 or 2 would represent a Buy, and a 3 rating would signify a Hold on the stock.
Shares of Atara Biotherapeutics, Inc. are presently 253.39% off the 52 week low. On the flip side, the stock is 2.33% away from the 52 week high. Current price levels see the company 25.60% off the 20-day simple moving average. The average volume stands around 928094. Trading volume may be a very important factor for any investor.
Disclaimer: The views, opinions, and information expressed in this article are those of the authors and do not necessarily reflect the official policy or position of any company stakeholders, financial professionals, or analysts. Examples of analysis performed within this article are only examples.
They should not be utilized to make stock portfolio or financial decisions as they are based only on limited and open source information. Assumptions made within the analysis are not reflective of the position of any analysts or financial professionals.